Braun Medical Inc recalls B. Braun — Ceftazidime for Injection USP (2g) and Dextrose for Injection USP (50 ml) in Duplex® Container
- Recall date
- April 20, 2020
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Braun Medical Inc, B. Braun
Why it was recalled
Out-of-Specification Results for High Molecular Weight Polymers — Ingredient Level
What was recalled
Ceftazidime for Injection USP (2g) and Dextrose for Injection USP (50 ml) in Duplex® Container
Read the official recall notice →
Get recall alerts
Free email alert whenever Braun Medical Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Braun Medical Inc, B. Braun